European regulators have validated Chiesi’s submissions for two next-generation propellant inhalers, part of the biopharma company’s shift toward lower-carbon respiratory products.

Enhertu in combination with pertuzumab has been approved in the European Union for the first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer – the first new regimen in this setting in more than a decade, AstraZeneca and Daiichi Sankyo announced.

With a new EUR 61 million facility in Vilnius, Northway Biotech becomes the first dedicated cell therapy and personalized medicine CDMO in the Baltics – a development that also expands manufacturing capacity within reach of the Nordic biotech sector.

Neola Medical has been granted Breakthrough Device Designation by the US FDA for Neola, its non-invasive lung monitor for preterm babies, designed to give early warning of life-threatening lung collapse.

Bioretec has received FDA 510(k) clearance for ActivaScrew Cannulated COM, a new bioabsorbable compression screw that expands its Activa implant portfolio into the US market.

The company has signed a distribution agreement with Malaysian medical device distributor OneMedik for its Glycosorb ABO product, extending the company’s international footprint into a new Southeast Asian market.

Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of Leqembi (lecanemab) for eligible Canadian patients with mild cognitive impairment or mild dementia due to Alzheimer’s disease, BioArctic’s partner Eisai announced.

The company has completed a directed share issue as it approaches proof-of-concept data from its Phase IIa study in chronic kidney disease with anemia, expected around the turn of the year.

Canada’s Drug Agency (CDA-AMC) has issued a final recommendation supporting public reimbursement of Leqembi (lecanemab) for eligible Canadian patients with mild cognitive impairment or mild dementia due to Alzheimer’s disease, BioArctic’s partner Eisai announced. The Swedish biotech invented the antibody and holds commercialisation rights to it in the Nordic region.

Ada Yonath, the 2009 Nobel laureate in Chemistry, died on August 31, 2026, at the age of 87. She was one of the first Nobel Prize laureates I interviewed as a new editor at Nordic Life Science – and the first I met in person, over an interview at the Grand Hotel in Stockholm. Yonath, who in 2009 became the first woman in 45 years to win the Nobel Prize in Chemistry, spoke to me about her curiosity, polar bears, extremely durable bacteria from the Black Sea, and her passion for science.

A study co-authored by a researcher with ties to Sweden’s Linköping University and University of Gothenburg has won the 2026 Ig Nobel Prize for Olfaction, awarded at the 36th First Annual Ig Nobel Prize ceremony – the first held outside the US in the prize’s 35-year history.

Professor Mia Phillipson, co-founder of Ilya Pharma, is one of this year’s recipients of the Olof Rudbeck Medals.